Glenmark Suffers US Ryaltris Setback Amid Search For A Partner

 
• By Aidan Fry

An FDA complete response letter issued to Glenmark for its Ryaltris olopatadine and mometasone combination nasal spray may make it more difficult for the Indian firm to find a US commercial partner for the seasonal rhinitis treatment.

Partnership
A complete response letter received for its Ryaltris nasal spray could complete plans to find a US commercial partner for the respiratory drug • Source: Shutterstock

More from Value Added Medicines

More from Products